Fatty Acid Amide Hydrolase (FAAH)—an upregulated serine hydrolase in tumors—regulates cancer proliferation, and its inhibitors exhibit anti-invasive/anti-metastatic effects, often synergizing with chemotherapeutics (261, 262); importantly, FAAH inhibitors are well-tolerated in clinical trials (263). Here, FAAH is linked to cancer.